Robert Paul Discordia - Net Worth and Insider Trading
Robert Paul Discordia Net Worth
The estimated net worth of Robert Paul Discordia is at least $50,857 dollars as of 2024-05-15. Robert Paul Discordia is the COO of Corbus Pharmaceuticals Holdings Inc and owns about 1,183 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $50,857. Details can be seen in Robert Paul Discordia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Paul Discordia has not made any transactions after 2020-03-17 and currently still holds the listed stock(s).
Transaction Summary of Robert Paul Discordia
Robert Paul Discordia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Paul Discordia owns 1 companies in total, including Corbus Pharmaceuticals Holdings Inc (CRBP) .
Click here to see the complete history of Robert Paul Discordia’s form 4 insider trades.
Insider Ownership Summary of Robert Paul Discordia
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2020-03-17 | Chief Operating Officer |
Robert Paul Discordia Latest Holdings Summary
Robert Paul Discordia currently owns a total of 1 stock. Robert Paul Discordia owns 1,183 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of March 17, 2020, with a value of $50,857.
Latest Holdings of Robert Paul Discordia
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2020-03-17 | 1,183 | 42.99 | 50,857 |
Holding Weightings of Robert Paul Discordia
Robert Paul Discordia Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Paul Discordia has made a total of 3 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the acquisition of 95 shares on March 17, 2020, which cost Robert Paul Discordia around $10,054.
Insider Trading History of Robert Paul Discordia
- 1
Robert Paul Discordia Trading Performance
GuruFocus tracks the stock performance after each of Robert Paul Discordia's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Paul Discordia is 33.83%. GuruFocus also compares Robert Paul Discordia's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Paul Discordia within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Paul Discordia's insider trading performs compared to the benchmark.
Performance of Robert Paul Discordia
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.63 | | | | | |
| Relative Return to S&P 500(%) | 9.02 | | | | | |
Robert Paul Discordia Ownership Network
Robert Paul Discordia Owned Company Details
What does Corbus Pharmaceuticals Holdings Inc do?
Who are the key executives at Corbus Pharmaceuticals Holdings Inc?
Robert Paul Discordia is the Chief Operating Officer of Corbus Pharmaceuticals Holdings Inc. Other key executives at Corbus Pharmaceuticals Holdings Inc include Chief Financial Officer Sean F. Moran , director & Chief Executive Officer Yuval Cohen , and Chief Commercial Officer Craig Stuart Millian .
Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Trades Summary
Over the past 18 months, Robert Paul Discordia made no insider transaction in Corbus Pharmaceuticals Holdings Inc (CRBP). Other recent insider transactions involving Corbus Pharmaceuticals Holdings Inc (CRBP) include a net purchase of 1,032,632 shares made by Cormorant Global Healthcare Master Fund, Lp , and a net purchase of 550,000 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) in total and bought 550,000 shares, with a net purchase of 550,000 shares. During the past 18 months, 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) were sold and 1,582,632 shares were bought by its insiders, resulting in a net purchase of 1,582,632 shares.
Corbus Pharmaceuticals Holdings Inc (CRBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corbus Pharmaceuticals Holdings Inc Insider Transactions
Robert Paul Discordia Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Paul Discordia. You might contact Robert Paul Discordia via mailing address: C/o Corbus Pharmaceuticals Holdings, Inc, 500 River Ridge Drive, Norwood Ma 02062.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
